Geode Capital Management, LLC Novo Nordisk A S Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $5.32 Million - $6.43 Million	-57,129 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $194,924 - $238,023	-2,033 Reduced 3.44%	57,129 $6.4 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $70,659 - $89,240	-837 Reduced 1.4%	59,162 $5.68 Million
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $384,850 - $482,114	5,688 Added 10.47%	59,999 $5.03 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $677,976 - $766,540	10,110 Added 22.87%	54,311 $3.66 Million
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $249,171 - $287,820	3,900 Added 9.68%	44,201 $3.09 Million
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $277,561 - $306,018	-4,358 Reduced 9.76%	40,301 $2.8 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $263,137 - $305,390	-4,495 Reduced 9.14%	44,659 $2.92 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $242,502 - $317,616	4,903 Added 11.08%	49,154 $2.96 Million
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $126,544 - $147,863	2,538 Added 6.08%	44,251 $2.56 Million
Q3 2019 Nov 12, 2019	BUY	$47.54 - $53.43 $84,050 - $94,464	1,768 Added 4.43%	41,713 $2.16 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $81,274 - $91,140	-1,737 Reduced 4.17%	39,945 $2.04 Million
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $80,666 - $91,576	1,740 Added 4.36%	41,682 $2.18 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $127,112 - $144,585	3,060 Added 8.3%	39,942 $1.84 Million
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $196,953 - $215,822	4,212 Added 12.89%	36,882 $1.74 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $169,409 - $192,856	3,825 Added 13.26%	32,670 $1.51 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $56,248 - $67,442	1,160 Added 4.19%	28,845 $1.42 Million
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $50,857 - $57,491	1,070 Added 4.02%	27,685 $1.49 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $50,408 - $60,294	1,225 Added 4.82%	26,615 $1.28 Million
Q2 2017 Aug 14, 2017	BUY	N/A	25,390	25,390 $1.09 Million

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$2.07 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.47 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.47 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.37 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.25 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account